Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Apitegromab (SRK-015), an investigational new drug developed by Scholar Rock, is a fully human IgG4 monoclonal antibody that specifically binds to human Pro-GDF8 or latent GDF8 without binding to mature GDF8 or other closely related growth factors
If youre interested in brand-name, FDA-approved GLP-1 injections like Mounjaro, Wegovy, Ozempic, and Zepbound, you can talk to your primary care physician or a general practitioner
Human distribution and release of a putative new gut hormone, peptide YY
If compounding becomes further restricted, your prescriber can help you transition to commercial Mounjaro, switch to compounded semaglutide which has different regulatory status, or explore other weight management options
Salas Whalen described it simply
